newsfilter
← Latest News
Business Wire·

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  • Mirum Pharmaceuticals granted inducement awards on November 10, 2026, under its 2020 Inducement Plan to 17 new employees.
  • The awards consist of non-qualified stock options for 26,126 shares & 34,386 restricted stock units (RSUs).
  • Stock options have an exercise price of $94.42 per share, matching the closing price on November 10, 2026.
  • Stock options vest over four years, with 25% vesting after one year & the remainder vesting monthly over the following 36 months.
  • RSUs vest over three years, with 33% vesting on each anniversary of the initial vesting date.
  • All awards are subject to continued service & the terms of Mirum's 2020 Inducement Plan & applicable award agreements.